Report overview
Human embryonic stem cell: also known as a human pluripotent stem cell, one of the "cells that are self-replicating, are derived from human embryos or human fetal tissue, and are known to develop into cells and tissues of the three primary germ layers.
This report aims to provide a comprehensive presentation of the global market for Human Embryonic Stem Cells (HESC), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Embryonic Stem Cells (HESC). This report contains market size and forecasts of Human Embryonic Stem Cells (HESC) in global, including the following market information:
Global Human Embryonic Stem Cells (HESC) Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Human Embryonic Stem Cells (HESC) Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Human Embryonic Stem Cells (HESC) companies in 2022 (%)
The global Human Embryonic Stem Cells (HESC) market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Totipotent Stem Cells Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Human Embryonic Stem Cells (HESC) include ESI BIO, Thermo Fisher, BioTime, MilliporeSigma (Merck), BD Biosciences, Astellas Institute of Regenerative Medicine, Asterias Biotherapeutics, PerkinElmer and Takara Bio, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Human Embryonic Stem Cells (HESC) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Human Embryonic Stem Cells (HESC) Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Human Embryonic Stem Cells (HESC) Market Segment Percentages, by Type, 2022 (%)
Totipotent Stem Cells
Pluripotent Stem Cells
Unipotent Stem Cells
Global Human Embryonic Stem Cells (HESC) Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Human Embryonic Stem Cells (HESC) Market Segment Percentages, by Application, 2022 (%)
Research
Clinical Trials
Others
Global Human Embryonic Stem Cells (HESC) Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Human Embryonic Stem Cells (HESC) Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Human Embryonic Stem Cells (HESC) revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Human Embryonic Stem Cells (HESC) revenues share in global market, 2022 (%)
Key companies Human Embryonic Stem Cells (HESC) sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Human Embryonic Stem Cells (HESC) sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
ESI BIO
Thermo Fisher
BioTime
MilliporeSigma (Merck)
BD Biosciences
Astellas Institute of Regenerative Medicine
Asterias Biotherapeutics
PerkinElmer
Takara Bio
Fujifilm Cellular Dynamics
Reliance Life Sciences
R&D Systems (Biotrchne)
STEMCELL Technologies
TATAA Biocenter
UK Stem Cell Bank
Viacyte, Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Human Embryonic Stem Cells (HESC), market overview.
Chapter 2: Global Human Embryonic Stem Cells (HESC) market size in revenue and volume.
Chapter 3: Detailed analysis of Human Embryonic Stem Cells (HESC) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Human Embryonic Stem Cells (HESC) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Human Embryonic Stem Cells (HESC) capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
